BIOMAT Database Logo BIOMAT Database Logo

Molecular iodine promoted synthesis of new pyrazolo[3,4-d]pyrimidine derivatives as potential antibacterial agents. 2010

Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Department of Chemistry, School of Sciences, Ferdowsi University of Mashhad, Vakilabad Blvd 91775-1436 Mashhad, Iran. mbakavoli@yahoo.com

Iodocyclization of 5-amino-1-(2,4-dinitrophenyl)-1H-4-pyrazolcarboxamides with aromatic aldehydes gave a new series of pyrazolo[3,4-d]pyrimidine derivatives in a single step and their antibacterial activity comparable to Streptomycin as reference drug was evaluated.

UI MeSH Term Description Entries
D007455 Iodine A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically. Iodine-127,Iodine 127
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D003500 Cyclization Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Cyclizations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
March 2006, Bioorganic & medicinal chemistry,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
November 2012, European journal of medicinal chemistry,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Pyrazolo[3,4-d]pyrimidine derivatives containing a Schiff base moiety as potential antiviral agents.
September 2018, Bioorganic & medicinal chemistry letters,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
[Synthesis of new derivatives of pyrazole and pyrazolo[3,4-d]pyrimidine].
January 1985, Acta poloniae pharmaceutica,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
November 2009, European journal of medicinal chemistry,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
June 2009, Archiv der Pharmazie,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
January 1987, Polish journal of pharmacology and pharmacy,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M.
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Design, synthesis and biological characteristics of pyrazolo[3,4-d]pyrimidine derivatives as potential VEGFR-2 inhibitors.
November 2022, Future medicinal chemistry,
Mehdi Bakavoli, and Ghodsieh Bagherzadeh, and Maryam Vaseghifar, and Ali Shiri, and Mehdi Pordel, and Mansour Mashreghi, and Parvaneh Pordeli, and Maryam Araghi
Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4-d]pyrimidine derivatives as anti-cancer agents.
June 2023, RSC advances,
Copied contents to your clipboard!